Autres langues Mega Lifesciences Thailand S.E.

Actions

MEGA-R

TH4984010R19

Produits pharmaceutiques

Cours en clôture Thailand S.E. 11/09/2026			Varia. 5j.	Varia. 1 janv.
36,50 ^THB	+2,10%		+1,39%	+8,96%

24/08	Transcript : Mega Lifesciences Public Company Limited, Q2 2026 Earnings Call, Aug 14, 2026
13/08	Mega Lifesciences Public Company Limited annonce le versement d'un dividende intérimaire pour la période du 1er janvier 2026 au 30 juin 2026, payable le 11 septembre 2026	CI

Autres langues

13/08	Mega Lifesciences Public Company Limited Announces Declaration of Interim Dividend for Period from 01 January 2026 to 30 June 2026, Payable on 11 September 2026
13/08	Mega Lifesciences Public Company Limited Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026
13/05	Mega Lifesciences Public Company Limited Reports Earnings Results for the First Quarter Ended March 31, 2026
03/04	Mega Lifesciences Public Company Limited Approves Final Cash Dividend for the Year Ended 31 December 2025, Payable on 24 April 2026
03/04	Mega Lifesciences Public Company Limited Appoints Plakorn Wanglee as an Independent Director
24/02	Mega Lifesciences Public Company Limited Proposes Final Cash Dividend for the Year Ended 31 December 2025, Payable on 24 April 2026
24/02	Mega Lifesciences Public Company Limited Approved Board and Committee Changes
24/02	Mega Lifesciences logs FY overall operating revenue 14,147 mln baht
24/02	Mega Lifesciences Public Company Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2025
13/11	Mega Lifesciences posts qtrly reported net profit 494 million baht
13/11	Mega Lifesciences Public Company Limited Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025
14/08/25	Mega Lifesciences Public Company Limited Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025
14/08/25	Mega Lifesciences posts qtrly operating revenue 3,953.8 million baht
14/08/25	Mega Lifesciences Public Company Limited Announces Interim Cash Dividend for the Period from 01 January 2025 to 30 June 2025, Payable on September 12, 2025
14/05/25	Mega Lifesciences Public Company Limited Reports Earnings Results for the First Quarter Ended March 31, 2025
04/04/25	Mega Lifesciences Public Company Limited Approves Final Dividend from the Operation Results for the Fiscal Year Ended December 31, 2024, Payable on April 24, 2025
24/02/25	Mega Lifesciences Public Company Limited Proposes Cash Dividend for the Year Ended 31 December, 2024, Payable on 24 April, 2025
24/02/25	Mega Lifesciences Public Company Limited Reports Earnings Results for the Full Year Ended December 31, 2024
12/11/24	Mega Lifesciences Public Company Limited Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024
13/08/24	Mega Lifesciences Public Company Limited Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2024
13/08/24	Mega Lifesciences Public Company Limited Announces Cash Dividend for the Period from 01-Jan-2024 to 30-Jun-2024, Payable on September 10, 2024
13/05/24	Mega Lifesciences Public Company Limited Reports Earnings Results for the First Quarter Ended March 31, 2024
22/02/24	Mega Lifesciences Public Company Limited Proposes Dividend for the Year Ended December 31, 2023, Payable on April 22, 2024
22/02/24	Mega Lifesciences Public Company Limited Reports Earnings Results for the Full Year Ended December 31, 2023
13/11/23	Mega Lifesciences Public Company Limited Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023